Clinical Trial Update: A Double-Blind, Randomized Comparative Study of Carliprazine and Aripiprazole in Patients with Acute Schizophrenia [Phase 3]

View source ↗

Summary

Phase 3 randomized, double-blind head-to-head trial comparing Carliprazine with Aripiprazole in adults with schizophrenia; status is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• ARIPIPRAZOLE (Aripiprazole)
• Carliprazine

Snippet

Sponsor: Chengdu Kanghong Pharmaceutical Group Co., Ltd. | Conditions: Acute Schizophrenia | Phase 3 | Status: NOT_YET_RECRUITING